ROMEO A MANDANAS

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology OKLAHOMA CITY, OK NPI 1114974466

General Payments — all program years on this page

$207,985.31

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 285
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $4,740.63 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $3,138.753
Long term medical supply or device loan $1,196.4012
Food and Beverage $381.554
Education $23.931

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $51,968.5360
2019 $63,645.61102
2020 $22,784.9629
2021 $21,275.0020
2022 $26,704.5330
2023 $16,866.0524
2024 $4,740.6320

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078857052 Janssen Scientific Affairs, LLC $150.00 08/28/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1078857100 Janssen Scientific Affairs, LLC $408.75 12/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1087147040 Novartis Pharmaceuticals Corporation $99.70 08/23/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1087147048 Novartis Pharmaceuticals Corporation $99.70 09/27/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1087147052 Novartis Pharmaceuticals Corporation $99.70 01/18/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1087147058 Novartis Pharmaceuticals Corporation $99.70 02/16/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1087147064 Novartis Pharmaceuticals Corporation $99.70 03/15/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1087147070 Novartis Pharmaceuticals Corporation $99.70 04/18/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1087147076 Novartis Pharmaceuticals Corporation $99.70 05/16/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1087147082 Novartis Pharmaceuticals Corporation $99.70 06/13/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1087147088 Novartis Pharmaceuticals Corporation $99.70 07/15/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1087147104 Novartis Pharmaceuticals Corporation $99.70 11/14/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1087147110 Novartis Pharmaceuticals Corporation $99.70 10/17/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1087147116 Novartis Pharmaceuticals Corporation $99.70 12/10/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1104428259 AstraZeneca Pharmaceuticals LP $116.93 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104627910 AstraZeneca Pharmaceuticals LP $122.13 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126831428 Genmab U.S., Inc. $24.58 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141267115 Incyte Corporation $2,580.00 03/08/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1147441292 Blueprint Medicines Corporation $117.91 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148885724 Sumitomo Pharma America, Inc. $23.93 04/10/2024 Education Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.